Unbound MEDLINE

[Thyroid function alterations in children with congenital cardiac disease after catheterization with iodinated contrast agents] Revista española de cardiología [Rev Esp Cardiol] Journal article

 
Title[Thyroid function alterations in children with congenital cardiac disease after catheterization with iodinated contrast agents]
Author(s)del Cerro Marín M, Fernández Ruiz A, García-Guereta L, Benito Bartolomé F, Burgueros M, Ares Segura S, Moreno F, Gracia Bouthelier R 
InstitutionServicios de Cardiología Pediátrica. Hospital Infantil La Paz. Madrid.
SourceRev Esp Cardiol 2000 Apr; 53(4):517-24.
MeSHChild, Preschool
Contrast Media
Female
Heart Catheterization
Heart Diseases
Humans
Hypothyroidism
Incidence
Infant
Infant, Newborn
Iodine Compounds
Male
Risk Factors
Thyroid Gland
Thyrotropin
Thyroxine
Time Factors
AbstractINTRODUCTION AND
OBJECTIVES: Iodinated contrast agents can block thyroid hormone synthesis. The aims of this study were: 1st) to study the incidence of thyroid function disturbances in children with congenital heart disease after cardiac catheterization, 2nd) to analyze the predisposing factors that may lead to the development of hypothyroidism after angiography, and 3rd) to determine the duration of these hypothyroidism states.
PATIENTS AND METHODS: From february 1993 to April 1997 thyrotropine (TSH) and free thyroxine (FT4) serum values were analyzed before cardiac catheterization and in the two following weeks, in 99 children under three years of age, with congenital cardiac disease. Those patients who showed any postangiography increase in TSH were further evaluated by weekly measures of serum thyroid hormones and TSH until normal values were obtained or until the initiation of hormonal replacement therapy. The patients' data (age, previous exposure to contrast agents, cardiac disease, associated extracardiac malformations, renal failure, severity of illness, treatment) and the catheterism data (the dose and type of contrast and the fluoroscopy time) were included in the univariant analysis.
RESULTS: 10 mUI/ml), that persisted beyond three weeks in six cases. The occurrence of multiple malformation syndromes was the most clearly associated risk factor (p < 0,01) not only in the development of postangiography hypothyroidism but also in longer hormonal dysfunction.
CONCLUSIONS: Thyroid function should be tested in every patient with multiple malformation syndrome that undergo angiocardiography with iodinated contrast agents.
Languagespa
Pub Type(s)English Abstract
Journal Article
PubMed ID10758029
  
Advertise on this site.